Dr. Stephen E. Wolverton, MD

Expert Publications

• Monitoring for adverse effects from systemic drugs used in dermatology.
• Pemphigus foliaceus with epidermal detachment: adverse events from patch testing.
• Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugs.
• The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
• Optimizing clinical use of azathioprine with newer pharmacogenetic data.
• Controversies in dermatologic drug therapy.
• Can short courses of systemic corticosteroids truly cause osteonecrosis?
• Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.
• Systemic drug therapy for psoriasis. The most critical issues.
• Recent trends in systemic psoriasis treatment costs.
• Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
• Top-accessed article: topical rapamycin.
• Drug hypersensitivity syndrome in a patient receiving vismodegib.
• Practice Gaps: Drug Reactions.
• Medical Malpractice in Dermatology-Part I: Reducing the Risks of a Lawsuit.

Media Releases

Get to know Dermatologist Dr. Stephen E. Wolverton, who serves the population of Indianapolis, Indiana.

Stephen E. Wolverton, MD is a dermatologist currently practicing with Indiana University Health. Indiana University Health is the largest network of physicians in the state of Indiana. A unique partnership with Indiana University School of Medicine, one of the nation’s leading medical schools, gives patients access to leading-edge medicine and treatment options that are available first, and often only, at IU Health.

After receiving his undergraduate degree at Ball State University in 1975, Dr. Wolverton attended medical school at Indiana University School of Medicine and received his MD degree in 1979.  Dr. Wolverton initially pursued a career in Family Practice, completing his residency at St. Elizabeth Medical Center in Dayton, Ohio in 1982. This residency was followed by a year in a junior faculty position at the same FP residency program.

Dr. Wolverton initiated his Dermatology career completing his residency at Wright State University in Dayton, Ohio, from 1983 to 1985. Subsequent faculty positions have included Wright State University (Fellow Instructor 1986-1987), Ohio State University (1987-1990, including a year as Acting Division Director), and the long-term faculty position in the Dermatology Department at the Indiana University School of Medicine (1990-present). His current position is Theodore Arlook Professor of Clinical Dermatology and Professor of Clinical Dermatology.

Dr. Wolverton’s long-term academic interest has been systemic drug use in Dermatology, focusing on all aspects of Drug Safety, including a more recent focus in the complex area of Drug Interactions. He is best known for his series of four books concerning Dermatologic Drug Therapy: Systemic Drugs for Skin Diseases (published in 1991) and Comprehensive Dermatologic Drug Therapy (initially published in 2001, 2nd edition published in February 2007, with the 3rd edition of this title published late Fall 2012).

In addition, for 20 years he has been the Course Director for the Introduction to Cutaneous Biology course for Dermatology residents throughout the US and Canada that is sponsored by the Indiana University Department of Dermatology. 

He is a frequent visiting professor at various Dermatology residency programs, along with various state and local Dermatologic medical societies. He continues his strong interest in Dermatology resident education full-time at IU and during many of the visiting professorships.

Dermatology is the branch of medicine dealing with the skin, nails, hair and its diseases. It is a specialty with both medical and surgical aspects. A dermatologist treats diseases, in the widest sense, as well as some cosmetic problems of the skin, scalp, hair, and nails.

Recommended Articles

• What Is Lipoma: Causes, Lipoma Removal, and What’s Involved?

  What is a lipoma?Lipoma is the most common benign tissue tumor that occurs in almost 1 percent of the population. A lipoma consists of mature fat cells. Typically, a lipoma is enclosed by a thin fibrous capsule. Usually, lipomas develop superficially under the skin, but they can also occur anywhere...

• Treatment Options for Teenage Acne

  Acne is normally caused by changing levels of hormones. This is why youths develop it during puberty or before getting their periods. Hormones are the culprits because they stimulate the oil-producing glands in the skin to produce more oil, which clogs the pores on the skin surface. There are few...

• 5 Ways to Prevent Ingrown Hairs

  It is important to realize that hair ingrowth is not a disease looking for a cure; rather, it is a condition that can be prevented if we dutifully stick to natural DIY remedies in the cozy comfort of our bedroom or boudoir. Perhaps the glaring exceptions would be vaginal or scrotal ingrowths that...

• Are All Fungal Skin Infections Contagious?

  Fungi are known to thrive in the human body, making their homes in moist areas where skin surfaces meet. The most common areas of the human body that are susceptible to fungal attacks are found in between the toes, in the genital area, and under the breasts.Most fungal skin infections are triggered...

• What are the Symptoms of Melanoma?

  Melanoma is an aggressive form of skin cancer that starts in the melanocytes, which are cells that produce pigments. It usually begins in tissues that are heavily pigmented, like moles and birthmarks. This form of skin cancer is often found in the chest, back, and palm, and in some rare cases, it...

• Syphilis: How Does It Affect Men and Women?

  Syphilis is a sexually transmitted disease that affects both men and women. The most common locations for the chancre to appear are in the penis, vagina, anus, and even in the oral cavity. There is not much difference in men and women as far as symptoms, diagnosis, and treatments are concerned....